Merus Stock Surges Over 35% On Strong Phase 2 Cancer Trial Results: What's Going On?

benzinga.com/25/05/45594630/merus-stock-surges-over-35-on-strong-phase-2-cancer-trial-results-whats-going-on

Merus N.V. (NASDAQ:MRUS) shares are trading higher Friday after the company reported promising interim results from its ongoing phase 2 trial evaluating petosemtamab in combination with pembrolizumab for head and neck cancer.
What To Know: The data, which will be formally presented at…

This story appeared on benzinga.com, 2025-05-23 19:18:14.
The Entire Business World on a Single Page. Free to Use →